The present invention relates to azaspiro derivatives of the formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the TRPM8 receptor.
[EN] AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS<br/>[FR] DÉRIVÉS AZASPIRO EN TANT QU'ANTAGONISTES DE TRPM8
申请人:RAQUALIA PHARMA INC
公开号:WO2015136947A1
公开(公告)日:2015-09-17
The present invention relates to azaspiro derivatives of the formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the TRPM8 receptor.